Diabetes Mellitus, Non-Insulin-Dependent

Search with Google Search with Bing
Information
Disease name
Diabetes Mellitus, Non-Insulin-Dependent
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02088658 Active, not recruiting N/A Technology Intensified Diabetes Education Study in African Americans May 2013 December 2024
NCT00004983 Completed N/A Education and Group Support for Diabetic Hispanics September 1999 December 2006
NCT00004992 Completed Phase 3 Diabetes Prevention Program July 1996 April 2001
NCT00006305 Completed Phase 3 Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes September 2000 March 2009
NCT00006432 Completed N/A Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes January 2000
NCT00010751 Completed Phase 2 Effects of Reiki on Painful Neuropathy and Cardiovascular Risk Factors September 1998 June 2004
NCT00013910 Completed Phase 1 NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes
NCT00029848 Completed Phase 3 Obese Patients With Type 2 Diabetes October 2001 May 2004
NCT00035542 Completed Phase 3 A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes. December 2001 October 2003
NCT00035568 Completed Phase 4 A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes February 2002 June 2003
NCT00035984 Completed Phase 3 Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus May 2002 August 2003
NCT00039026 Completed Phase 3 Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea February 2002 August 2003
NCT00044395 Completed Phase 3 Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes July 2002 October 2005
NCT00044408 Completed Phase 3 Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes July 2002 October 2005
NCT00044447 Completed Phase 3 Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione May 2001 September 2002
NCT00044694 Completed Phase 2 Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus August 2002 May 2003
NCT00044707 Completed Phase 2 Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide August 2002 September 2002
NCT00065312 Completed Phase 2 An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes
NCT00069784 Completed Phase 3 The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention) August 2003 December 2011
NCT00071422 Completed Phase 2 Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes October 2003 June 2004
NCT00160017 Completed Effectiveness and Cost-effectiveness of the Diabetes Integrated Care Breakthrough Collaborative January 2005 March 2008
NCT00172536 Completed N/A Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass Graft October 2004 February 2006
NCT00264394 Completed Phase 4 Cardiovascular Risk Factor Management in HIV Infection July 2006 February 2010
NCT00320853 Completed N/A A Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Sensitivity and Secretion April 2006 May 2006
NCT00347542 Completed N/A A Trial to Study the Effect of Vitamin D Supplementation on Glucose and Insulin Metabolism in Centrally Obese Men July 2006 October 2007
NCT00411554 Completed Phase 3 A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED) January 2007 August 2007
NCT00545584 Completed Phase 3 Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078) April 1, 2007 November 19, 2009
NCT00550329 Completed Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets October 2007 November 2007
NCT00701090 Completed Phase 3 A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED) May 2008 October 2009
NCT00754130 Completed Phase 1 MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011). September 2008 October 2008
NCT00758069 Completed Phase 2 Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045) July 3, 2005 February 13, 2006
NCT00791661 Completed Phase 1 MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005) November 2008 March 2009
NCT00837577 Completed Phase 3 MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104) February 5, 2009 August 11, 2010
NCT00875394 Completed Phase 3 Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189) February 1, 2007 June 27, 2008
NCT00929838 Completed N/A Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM August 2008 June 2016
NCT00952991 Completed Phase 3 The Effects of LAF237 on Gastric Function in Type 2 Diabetes May 2005 February 2006
NCT00979368 Completed Phase 1 Safety Study of BMS-816336 in Healthy Male Subjects November 2009 February 2010
NCT01105429 Completed Phase 1 Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes May 2010 October 2010
NCT01299844 Completed N/A Impact of Type 2 Diabetes Peer Counseling on Behavioral, Metabolic, and Health Outcomes Among Latinos December 2006 September 2010
NCT01309620 Completed Phase 2/Phase 3 Zinc Supplementation in Type 2 Diabetics January 2009 March 2010
NCT01393275 Completed N/A Effects of Exercise Intervention and Rehabilitation Exercise Intervention in Patients With Type 2 Diabetes February 2010 October 2011
NCT01608724 Completed Phase 4 The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus November 2012 May 2014
NCT01694758 Completed OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA November 2012 March 2014
NCT01730534 Completed Phase 3 Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events April 25, 2013 September 11, 2018
NCT01812122 Completed Phase 4 Effects of Vildagliptine and Glimepiride on Glucose Variability March 2013 October 2015
NCT02801448 Completed Phase 2 Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes September 2015 June 2020
NCT02661906 Completed N/A A Pilot Study on Effect of SKY on Psychosocial Parameters of Type 2 Diabetic Patients After a 6 Days August 2016 February 2018
NCT02662400 Completed Phase 2/Phase 3 Assessment of Insulin Sensitivity and β Cell Function by Clamps Studies January 2016 December 2016
NCT02690766 Completed N/A Translating Healthy Lifestyle Interventions for Cancer Survivors March 2015 May 2016
NCT02770235 Completed N/A Evaluation of Advanced Glycation End-products (AGE) and the Erectile Dysfunction (DE) in Diabetic Patients March 17, 2014 March 16, 2019
NCT02113163 Completed Phase 1 PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA March 2014 July 2014
NCT02128854 Completed N/A Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills August 14, 2014 August 31, 2016
NCT02189135 Completed Phase 4 Making Ramadhan Fasting a Safer Experience With Technology Study July 2014 September 2016
NCT02299388 Completed Phase 4 To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study October 2014 December 2016
NCT02481479 Completed Phase 4 Saxagliptin and Cardiac Structure and Function June 2015 August 2018
NCT02541734 Completed Phase 1/Phase 2 Effect of Gelofusine on GLP1-receptor Imaging August 2015 May 2017
NCT02585505 Completed Phase 1/Phase 2 Tissue Distribution of F18-FDG Labeled ABMSCT in Patients With Type2 Diabetes Mellitus December 2010 December 2012
NCT02091323 Unknown status N/A Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Non-severe Obesity With Type 2 Diabetes Mellitus March 2014 December 2017
NCT00004572 Unknown status Identification and Therapy Efficacy of Type 2 Diabetes in Hispanic Patients
NCT02196272 Unknown status N/A Nurse-led Reminder Program for Therapy Adherence, Clinical Outcomes and Trust in Nurses in Diabetic Patients July 2014
NCT01377961 Withdrawn N/A Effect of Lycopene and Isoflavones on Glucose Metabolism September 2010 August 2015